This pack has been prepared to aid discussion and provide further supplementary information only and has not been subject to an external review or audit -- 1 of 18 -- CUSTOMERS PER ENTITY Life Policyholders December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 450 866 449 211 449 300 447 690 449 130 449 020 449 378 448 313 445 813 446 713 452 561 446 475 Invest Invest - DRO 137 441 137 503 137 718 137 189 135 819 134 721 133 741 132 817 131 244 129 606 127 831 124 135 Invest - Other 236 055 229 871 225 414 221 273 216 479 212 161 206 778 201 210 195 231 192 615 189 210 185 025 Group (lives) 707 154 711 051 707 756 711 161 680 754 584 081 562 769 576 450 562 440 578 035 551 219 544 443 Group schemes 2 581 2 616 2 647 2 663 2 666 2 793 2 844 2 827 2 825 2 797 2 740 2 771 Life NB APE 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to R million December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 1 440 2 778 1 444 2 663 1 355 2 362 1 204 2 072 1 068 2 126 1 165 2 215 Group 23 164 75 175 130 181 64 193 94 160 75 97 Invest - Recurring 867 1 673 851 1 551 796 1 428 737 1 167 573 1 164 686 1 221 Invest - Single APE1 867 1 627 778 1 500 708 1 493 782 1 570 744 1 508 671 1 382 Total Life APE 3 197 6 242 3 148 5 889 2 989 5 463 2 786 5 001 2 478 4 958 2 597 4 915 1 APE shown at 10% of Single premium Health Members December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 DHMS - Keycare 204 847 207 934 226 848 225 517 232 988 232 055 234 421 235 841 230 960 232 714 243 046 240 140 DHMS - Non-Keycare 1 154 532 1 152 395 1 147 016 1 149 861 1 142 556 1 135 853 1 118 591 1 111 545 1 099 553 1 111 079 1 108 674 1 110 401 In-House Schemes 356 504 354 944 321 333 319 813 321 838 318 246 316 973 321 613 321 767 319 974 317 408 316 410 Total 1 715 883 1 715 273 1 695 197 1 695 191 1 697 382 1 686 154 1 669 985 1 668 999 1 652 280 1 663 767 1 669 128 1 666 951 Health Lives December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 DHMS - Keycare 343 648 350 038 385 906 384 759 398 397 397 595 401 307 404 984 400 108 403 392 420 869 415 436 DHMS - Non-Keycare 2 391 556 2 394 452 2 402 336 2 413 851 2 412 595 2 406 528 2 383 486 2 375 082 2 358 232 2 381 735 2 387 237 2 394 336 In-House Schemes 800 093 798 933 710 485 707 406 710 427 704 472 699 342 707 293 704 749 698 534 689 688 686 114 Total 3 535 297 3 543 423 3 498 727 3 506 016 3 521 419 3 508 595 3 484 135 3 487 359 3 463 089 3 483 661 3 497 794 3 495 886 Vitality SA December 2024 June 2024 December 2023 June 2023 December 20222 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Total Vitality Health, Vitality Drive and Vitality Money programme lives 3 038 785 2 922 347 2 822 972 2 652 877 2 498 048 2 348 834 2 242 401 2 163 411 2 122 453 2 065 868 2 060 011 1 987 237 2 restated to include for LA wellness figures VitalityHealth Members December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 141 014 140 400 138 278 135 117 129 568 124 395 117 007 113 189 108 955 105 915 104 997 101 702 SME 344 320 340 983 327 876 310 624 285 865 263 216 238 540 222 961 211 949 212 305 209 509 201 960 Corporate 128 241 120 685 112 941 108 191 102 823 99 578 89 881 86 149 80 514 81 124 78 050 70 583 Trust and Cost Plus 20 198 20 237 16 448 16 339 14 511 8 698 3 944 2 731 2 639 - - - Total 633 773 622 305 595 543 570 271 532 767 495 887 449 372 425 030 404 057 399 344 392 556 374 245 VitalityHealth Lives December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 261 481 260 210 256 527 250 551 238 629 227 684 212 896 204 890 195 996 188 976 186 559 179 811 SME 545 424 541 111 522 753 496 299 460 442 429 110 395 777 374 179 357 768 356 907 353 763 342 431 Corporate 202 151 191 015 178 163 171 364 163 120 158 890 148 654 143 905 135 218 135 440 131 991 120 157 Trust and Cost Plus 35 214 35 163 27 349 26 854 22 673 15 903 6 509 4 066 3 956 - - - Total 1 044 270 1 027 499 984 792 945 068 884 864 831 587 763 836 727 040 692 938 681 323 672 313 642 399 VitalityLife Policies December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Policies 782 296 679 382 646 564 622 451 593 322 565 778 535 281 517 913 493 970 474 890 458 675 434 678 VitalityLife Lives December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Lives3 852 154 810 050 782 296 764 699 735 137 702 105 669 139 647 020 617 051 594 799 577 965 549 526 3 restated to include unique lives only Discovery Insure Policies December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Policies 213 762 214 297 215 297 211 223 214 315 213 453 212 570 202 335 191 936 178 517 169 920 159 171 Discovery Bank December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Primary Clients 1 092 386 958 055 825 069 702,131 581 457 470 220 385 177 331 088 287 183 206 810 61 731 1 476 Total Accounts 2 608 023 2 271 703 1 933 839 1,625,912 1 312 970 1 023 790 793 215 648 546 521 081 357 416 141 660 3 740 2 Membership -- 2 of 18 -- VALUE OF NEW BUSINESS AT POINT OF SALE VS VALUATION DATE December 2024 VNB at Point of Sale R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Acquisition Costs and Initial strain (264) (1 446) (808) (1 685) (4 203) Value of In Force 757 1 721 1 015 1 788 5 281 Cost of Capital (21) (36) (26) (42) (125) 472 239 181 61 953 New business contribution to value of in force at valuation date R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Value of In Force 755 1 277 982 1 642 4 656 Cost of Capital (21) (36) (26) (42) (125) 734 1 241 956 1 600 4 531 June 2024 VNB at Point of Sale R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Acquisition Costs and Initial strain (550) (2 833) (1 560) (1 132) (6 075) Value of In Force 1 653 3 393 2 051 1 074 8 171 Cost of Capital (52) (79) (63) (70) (264) 1 051 481 428 (128) 1 832 New business contribution to value of in force at valuation date R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Value of In Force 1 615 2 454 1 906 909 6 884 Cost of Capital (51) (79) (60) (68) (258) 1 564 2 375 1 846 841 6 626 December 2023 VNB at Point of Sale R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Acquisition Costs and Initial strain (253) (1 452) (754) (635) (3 094) Value of In Force 659 1 739 999 535 3 932 Cost of Capital (21) (45) (53) (35) (154) 385 242 192 (135) 684 New business contribution to value of in force at valuation date R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Value of In Force 660 1 256 960 513 3 389 Cost of Capital (21) (45) (52) (28) (146) 639 1 211 908 485 3 243 3 Value of New Business -- 3 of 18 -- EV RECONCILIATION TO INCOME STATEMENT for the year ended 31 December 2024 R million Embedded Value Earnings Value of In- Force Cost of required Capital Impact on Income Statement Adjustment to Shareholders Funds Statement of Changes in Equity Total profit from new business (at point of sale) 953 4 497 (125) (3 419) - Health and Vitality 472 734 (21) (241) - - - Life 239 1 241 (36) (966) - - - VitalityHealth 181 950 (26) (743) - - - VitalityLife 61 1 572 (42) (1 469) - - Profit from existing business * Expected return 5 268 925 (12) 4 355 - Health and Vitality 1 981 306 3 1 672 Expected transfer from VIF to net worth - (1 672) - 1 672 Unwinding of the risk discount rate 1 981 1 978 3 - - Life 2 265 1 236 - 1 029 Expected transfer from VIF to net worth - (1 029) - 1 029 Unwinding of the risk discount rate 2 265 2 265 - - - VitalityHealth 458 (578) (14) 1 050 Expected transfer from VIF to net worth - (1 050) - 1 050 Unwinding of the risk discount rate 458 472 (14) - - VitalityLife 564 (39) (1) 604 Expected transfer from VIF to net worth - (604) - 604 Unwinding of the risk discount rate 564 565 (1) - * Change in methodology and assumptions 1 241 (764) (38) 2 043 - Health and Vitality (97) (117) 20 - - Life 1 487 1 152 (51) 386 - VitalityHealth - - - - - VitalityLife (149) (1 799) (7) 1 657 * Experience variances 1 447 1 181 80 186 - Health and Vitality 22 (17) - 39 - Life 468 436 - 32 - VitalityHealth 816 807 81 (72) - VitalityLife 141 (45) (1) 187 Increase in goodwill and intangibles (179) - - - (179) - Other initiatives 1 160 9 - 1 151 - - Non-recurring expenses (103) - - (103) - - Acquisition costs (11) (2) - (9) - - Finance costs (1 633) - - (1 633) - - Other (4) (1) 1 - (4) - Foreign Exchange Rate Movements 1 125 701 (21) (299) (85) 829 Intangibles (85) - - - (85) - Other 1 210 701 (21) (299) - 829 Return on shareholders' funds 799 - - 755 - 44 Unrealised gain on investments and realised gain on investments transferred to income statement 630 - - 586 - 44 Health and Vitality investment income 37 - - 37 - - Life investment income 132 - - 132 - - VitalityHealth investment income - - - - - - VitalityLife investment income - - - - - - Amortisation of Intangibles (30) - - (227) 197 - Amortisation of intangibles from business combinations (30) - - (44) 14 - Amortisation of systems intangibles - - - (183) 183 - VitalityHealth and VitalityLife DAC and unemployment reserve - - - 292 (292) - Reversal of 1 Discovery Place IFRS 16 financial lease accounting - - - (54) 54 - Life assets under insurance contracts - - - 1 906 (4 117) 2 211 VitalityLife net assets under insurance contracts - - - (418) 135 283 VitalityHealth Insurance Acquisition Cash Flow (IACF) asset - - - 30 (30) - VitalityHealth FinRe - - - 292 (292) - Equity settled share based payment mark-to-market adjustment - - - (227) 227 - Embedded value earnings 10 033 6 546 (115) 4 329 (4 094) 3 367 Adjustment to Shareholders' Funds: Change in: * VitalityHealth Insurance Acquisition Cash Flow (IACF) asset (322) Intangibles & Goodwill (71) Life net assets under insurance contracts (4 117) VitalityLife net assets under insurance contracts 135 1 DP IFRS 16 financial lease accounting 54 Equity settled share based payment mark-to-market adjustment 227 * The total change in the net assets under insurance contracts consists of the change in the Negative Rand Reserve (NRR), which is zeroised in the embedded value. The change in the NRR is split between the Income Statement and the change in Other Comprehensive Income (OCI) which flows through the Statement of Changes in Equity (SOCIE). 4 EV recon -- 4 of 18 -- EV BUILD-UP PER ENTITY for the year ended 31 December 2024 R million Health and Vitality Life and Invest VitalityHealth VitalityLife Other Total Value of in-force business at 30 June 2024 26 914 35 813 13 904 14 435 - 91 066 Expected return (in-force business) 1 962 2 228 448 533 - 5 171 Release of profits (in-force business) (1 672) (1 029) (1 050) (604) - (4 355) Value of new business 736 1 685 989 1 746 - 5 156 Expected return (new business) 19 37 10 31 - 97 Release of profits (new business) (23) (480) (65) (216) - (784) Experience variances (17) 436 888 (46) - 1 261 Methodology changes (97) 1 101 - (1 806) - (802) Other (1) 8 350 330 - 687 Value of in-force business at 31 December 2024 27 821 39 799 15 474 14 403 - 97 497 Shareholders’ funds per Balance Sheet 4 474 34 211 9 992 4 313 11 654 64 644 Adjustment to shareholders' funds - (23 982) (4 673) (11 187) (2 683) (42 525) Embedded value at 31 December 2024 32 295 50 028 20 793 7 529 8 971 119 616 5 EV Buildup per Entity -- 5 of 18 -- COMPONENTS OF ASSETS UNDER INSURANCE CONTRACTS AND ADJUSTMENT TO SHAREHOLDERS' FUNDS ON PUBLISHED BASIS R million December 2024 1. Assets under insurance contracts Discovery Life positive liabilities not netted off with negative liabilities: 628 Discovery Life long term reserves in respect of policies with net negative liabilities: (35 813) Working capital 226 Discovery Life liability for incurred claims (LIC) 7 731 Total Assets under insurance contracts: (27 228) 0 2. Negative liabilites not included under assets under insurance contracts Negative reserve in respect of Invest business (7 351) DAC and DRL in respect of Invest business (773) (8 124) - 3. Components to be zeroised based on the Method of Distributable Cashflows: - Discovery Life long term reserves in respect of policies with net negative liabilities: (35 813) Liabilities under reinsurance contracts* 462 Negative reserve in respect of Invest business (7 351) DAC and DRL in respect of Invest business (773) Adjust for reduction on Deferred Tax Liability as a result of reduction in earnings 7 678 Liabilities off set against Negative reserve before zeroisation 11 815 (23 982) * This amount is the liability under reinsurance contracts, net of CSM, in respect of the portion of the gross assets under insurance contracts zeroised based on the method of distributable cashflows. 4. Other adjustments to published Shareholders' funds VitalityLife net assets under insurance contracts (11 179) VitalityHealth Insurance Acquisition Cash Flow (IACF) asset (4 673) VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) (8) Goodwill (2 922) Intangible assets (net of deferred tax) relating to the acquisition of Standard Life Healthcare and the Prudential Assurance Company joint venture (807) Net preference share capital (779) Reversal of 1 Discovery Place IFRS 16 financial lease accounting 1 516 Equity settled share based payment mark-to-market adjustment 309 Adjustment to Shareholders' funds from published basis (42 525) 6 EV Adjustment to SH funds -- 6 of 18 -- RECONCILIATION TO THE REQUIRED CAPITAL for the year ended 31 December 2024 R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Opening - 30 June 2024 1 238 27 935 4 138 11 299 44 610 - Methodology and Basis Changes - 1 050 - (110) 940 - Expected release on in-force at start of period (56) (446) (74) (349) (925) - Impact of new business written 87 445 223 1 061 1 816 - Other changes* 11 1 301 (28) 16 1 300 - Exchange rate movements - 89 276 365 Change in Required Capital 42 2 350 210 894 3 496 Closing - 31 December 2024 1 280 30 285 4 348 12 193 48 106 *This line includes, amongst other things, the impact of rebasing the yield curve as part of the opening to closing reconciliation of required capital. This component of the expected yield curve unwind is shown separately from the expected release for information purposes only. 7 Recon of Required Capital -- 7 of 18 -- BREAKDOWN OF INVEST ASSETS UNDER ADMINISTRATION R million Total December 2021 127 632 June 2022 121 737 December 2022 130 830 June 2023 140 378 December 2023 144 810 June 2024 154 653 December 2024 166 915 8 Invest AUA -- 8 of 18 -- SA SA SA SA SA UK UK ALL OTHER SEGMENT IFRS R million HEALTH LIFE INVEST INSURE BANK HEALTH LIFE SEGMENTS TOTAL TOTAL 31 December 2024 Income statement Insurance revenue 236 9 286 2 209 3 078 - 9 112 3 758 95 27 774 - 27 774 - Contracts measured under the General measurement model/Variable fee approach - 7 437 2 209 - - - 3 758 - 13 404 - 13 404 - Contracts measured under Premium allocation approach 236 1 849 - 3 078 - 9 112 - 95 14 370 - 14 370 Insurance service expenses ( 146) (7 837) (1 327) (2 690) - (8 280) (3 290) ( 111) (23 681) - (23 681) - Claims and benefits ( 94) (5 788) ( 295) (1 568) - (5 367) (1 693) ( 74) (14 879) - (14 879) - Insurance service expense and other ( 27) ( 990) ( 522) ( 672) - (1 957) ( 173) ( 33) (4 374) - (4 374) - Insurance acquisition cash flows ( 25) (1 059) ( 510) ( 450) - ( 956) (1 424) ( 4) (4 428) - (4 428) Insurance service result (pre-reinsurance) 90 1 449 882 388 - 832 468 ( 16) 4 093 - 4 093 Net income/(expenses) from reinsurance contracts ( 1) ( 530) - ( 52) - - ( 239) 6 ( 816) - ( 816) - Reinsurance expense ( 1) (1 876) - ( 66) - ( 2) (4 270) ( 33) (6 248) - (6 248) - Insurance claims recovered from reinsurers - 1 346 - 14 - 2 4 031 39 5 432 - 5 432 Insurance service result 89 919 882 336 - 832 229 ( 10) 3 277 - 3 277 Net financial result from insurance finance income and expense - 1 350 (7 454) - - - 145 - (5 959) ( 47) (6 006) - Net finance income/(expense) from insurance contracts - 1 421 (7 454) - - - 273 - (5 760) ( 47) (5 807) - Net finance income/(expense) from reinsurance contracts - ( 71) - - - - ( 128) - ( 199) - ( 199) Investment income using the effective interest rate method 9 2 42 123 - 51 44 8 279 182 461 Net fair value (losses)/gains on financial instruments at fair value through profit or loss 6 267 8 216 8 ( 1) 60 - 1 317 9 873 2 764 12 637 Fair value adjustments to liabilities under investment contracts - - ( 602) - - - - (1 317) (1 919) - (1 919) Third-party interest: fair value adjustments to liabilities under investment contracts - - - - - - - - - (2 401) (2 401) Intersegment funding - 237 ( 237) - - - - - - - - Other gains/(losses) on financial instruments - - - - ( 9) - - - ( 9) - ( 9) Net insurance and investment results 104 2 775 847 467 ( 10) 943 418 ( 2) 5 542 498 6 040 Fee income from administration businesses 4 744 - 989 - - 17 - 1 630 7 380 ( 66) 7 314 Vitality income - - - - - 16 128 2 741 2 885 ( 267) 2 618 Net banking fee and commission income - - - - 611 - - ( 30) 581 150 731 - Banking fee and commission income - - - - 1 036 - - - 1 036 - 1 036 - Banking fee and commission expense - - - - ( 425) - - ( 30) ( 455) 150 ( 305) Net banking interest and similar income - - - - 489 - - - 489 - 489 - Banking interest and similar income using the effective interest rate - - - - 1 105 - - - 1 105 - 1 105 - Banking interest and similar expense using the effective interest rate - - - - ( 616) - - - ( 616) - ( 616) Other income 882 61 - 16 21 10 - 7 161 8 151 (7 215) 936 Non-insurance revenue and income 5 626 61 989 16 1 121 43 128 11 502 19 486 (7 398) 12 088 Net income 5 730 2 836 1 836 483 1 111 986 546 11 500 25 028 (6 900) 18 128 Non-insurance acquisition costs - - ( 486) - - - - ( 114) ( 600) - ( 600) Expected credit losses - - - - ( 118) - - - ( 118) - ( 118) Marketing and administration expenses (3 707) ( 224) ( 446) ( 118) (1 138) ( 387) ( 221) (11 473) (17 714) 7 181 (10 533) Share of net profits from equity-accounted investments - - - 36 - - 2 386 424 ( 25) 399 Normalised profit/(loss) from operations 2 023 2 612 904 401 ( 145) 599 327 299 7 020 256 7 276 Investment income earned on shareholder investments and cash 43 14 5 - - - - 120 182 ( 182) - Intercompany investment income - - - - - - - 681 681 ( 681) - Net fair value (losses)/gains on financial assets at fair value through profit or loss - 41 35 - - - - 2 78 ( 78) - Gain/(Loss) from dilution of equity accounted investments - - - ( 26) - - - - ( 26) - ( 26) Gain/(Loss) as a result of obtaining or losing control of previously held interest - - - - - - - - - - - Impairment of goodwill - - - - - - - - - - - Amortisation of intangibles from business combinations - - - ( 25) - - - ( 29) ( 54) 54 - Market rentals related to Head Office building adjusted for finance costs and depreciation - - - - - - - ( 44) ( 44) 44 - Restructuring costs - - - - - - - ( 46) ( 46) 46 - Interest expenses on borrowings and lease liabilities ( 1) - - - - ( 10) ( 104) ( 839) ( 954) ( 140) (1 094) Intercompany finance expenses on borrowings ( 222) - - - - - ( 225) ( 234) ( 681) 681 - Foreign exchange gains/(losses) ( 2) 3 ( 6) - - - - 18 13 - 13 Profit/(loss) before income tax 1 841 2 670 938 350 ( 145) 589 ( 2) ( 72) 6 169 - 6 169 Income tax expense ( 497) ( 715) ( 401) ( 101) 32 ( 147) ( 31) 20 (1 840) - (1 840) Profit/(loss) for the period 1 344 1 955 537 249 ( 113) 442 ( 33) ( 52) 4 329 - 4 329 Profit attributable to: - Ordinary shareholders 1 347 1 955 537 249 ( 113) 442 ( 33) ( 99) 4 285 - 4 285 - Preference shareholders - - - - - - - 47 47 - 47 - Non-controlling interest ( 3) - - - - - - - ( 3) - ( 3) Segment information IFRS REPORTING ADJUSTMEN -- 9 of 18 -- VIF, APE AND VNB SPLIT BETWEEN LIFE AND INVEST R million December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 VIF1 Life 27 082 24 138 22 859 22 244 23 133 22 059 Invest 12 715 11 675 10 429 9 393 9 521 8 505 APE2 Life 355 804 426 823 463 837 Invest 1 234 2 411 1 150 2 142 1 033 2 158 VNB1 Life 94 225 136 162 169 364 Invest 145 256 106 267 160 341 1 These VIF and VNB numbers are after allowing for the Cost of required Capital. 2 APE is the Annual Premium Income (or Annual Premium Equivalent in the case of Single Premium Investment business) in relation to New Business only, and excludes any addition to Existing Business premiums arising from servicing increases and ACIs. Discovery Retirement Optimiser (DRO) product moved from Life to Invest in line with disclosures for December 2016 and later periods. 10 Results split Life and Invest -- 10 of 18 -- Group Shareholder Free Cash Movement R millions H1 FY2025 FY2024 H1 FY2024 FY2023 Cash Generated from In-Force Before Financing and Tax 8 319 14 617 7 567 14 425 New Business Net of External Financing (3 506) (6 823) (3 528) (7 243) Tax Paid (758) (1 522) (792) (1 839) Operating Cash Flow 4 055 6 272 3 247 5 343 New Initiatives (727) (1 025) (776) (1 671) Business Development and Other (594) (1 580) (864) (1 274) Finance Cost Paid (899) (1 566) (802) (1 501) Dividends Paid (1 073) (1 270) (783) (69) Financing and Matching Initiatives (236) (496) (332) 166 Transactions with Borrowers (Excl. Finance Costs) (491) 1 130 (80) (597) Movement in Shareholder Free Cash 35 1 465 (390) 397 Remove ordinary dividends paid in period 1 028 1 179 740 - Add ordinary dividends payable in respect of period (591) (1 467) (439) (740) Movement in Shareholder Free Cash – Dividend Accrual Basis (1) 437 1 177 (89) (343) Operating Cash Flow 4 055 6 272 3 247 5 343 IFRS Normalised Operating Profit net of Tax Expense 5 436 9 465 4 343 8 356 Cash Conversion Ratio 75% 66% 75% 64% The cash conversion ratio is calculated as Operating Cash Flow per the Group shareholder free cash movement, divided by Normalised profit from operations (IFRS total) net of Income tax expense (IFRS total) per A.1 Segment Information. Restatement of Operating Cash Flow The following table indicates the portion of "Operating Cash Flow" representing the net external FinRe cash flows for VitalityLife, previously disclosed in "Financing and Matching Activities": R millions H1 FY2025 FY2024 H1 FY2024 FY2023 Operating Cash Flow - Before Net New Business Funding (Repayments and Funding) 3 332 5 322 2 902 5 337 Net New Business Funding (Repayments and Funding) 723 950 345 6 Operating Cash Flow 4 055 6 272 3 247 5 343 Group Shareholder Free Cash Movement - Reconciliation to Profit for the Period R millions H1 FY2025 FY2024 H1 FY2024 (2) FY2023 (2) Profit for the period 4 329 7 364 3 278 6 572 Reverse non-cash profit items: Share of net (profits)/losses from equity accounted investments (425) (1 031) (302) (561) Losses/(gains) from dilution of equity accounted investments 26 (22) - 5 Depreciation and amortisation 1 074 2 160 1 040 1 972 Impairment of intangible assets 21 45 4 61 Deferred acquisition costs (Excl. Invest DAC and exchange rate movements) - - - (42) Movement in contract assets (462) (640) (252) 52 Amortisation of intangibles from business combinations - - - 56 Non cash impact of Vitality Health DAC (217) (411) (206) (753) Non-cash fair value gains on financial assets (47) (87) (56) (214) Non-cash forex gains / losses - - - 9 Bank interest income incurred to cash (277) - - - Other non-cash adjustments to profit (327) (152) (64) (178) Adjustments from IFRS to EV ANW: Increase in Negative Reserves and Invest DAC (Net of tax) (1 487) (4 547) (1 702) (5 393) Exchange rate movements on Vitality Life Negative Reserves 206 (385) (137) 1 900 Other adjustments to arrive at EV ANW 404 1 644 137 196 Incurred to Cash basis: - Rent Paid (329) (511) (286) (328) - Finance Costs Paid (1 494) (2 603) (802) (1 501) - Finance Costs Accrued 1 711 3 097 1 025 1 941 - Taxation paid (758) (1 522) (792) (1 839) - Taxation Accrued 654 1 093 810 1 495 Investing Activities: Purchase of property and equipment (120) (414) (246) (551) Proceeds from disposal of property and equipment 3 28 - 2 Purchase of intangible assets (875) (1 789) (800) (1 760) Increase in investment in associate 294 287 (176) (75) Acquisition of business net of cash required (304) - - (3) Cash proceeds from CMT transaction - - - - Financing Activities: Increase in borrowings 1 765 2 005 500 7 441 Repayment of borrowings (2 257) (874) (580) (8 038) Dividends paid to ordinary shareholders (1 026) (1 179) (739) - Dividends paid to preference shareholders (47) (91) (44) (69) Movement in Shareholder Free Cash 35 1 465 (390) 397 Notes From FY2024, and restated for prior periods, the net external FinRe cash flows for VitalityLife (relating to the partial funding of new business acquisition costs) have been reallocated to “Operating Cash Flow”, with FinRe repayments included in "Cash Generated from In-Force Before Financing and Tax" and new FinRe receivables offset against "New Business Net of External Financing". Previously, the net external FinRe cash flows for VitalityLife were included in “Financing and Matching Activities”. Vitality Life utilises FinRe to manage the upfront acquisition costs of writing new business. To the degree that FinRe is raised specifically for the purpose of writing new business, management believes offsetting this funding against new business acquisition costs is a more informative representation of operational cash flow, which has led to this enhancement. The increased use of FinRe in the reporting period follows the significant increase in new business volumes in VitalityLife from FY2024, represented in "New Business Net of External Financing" in the Movement in Shareholder Free Cash. "Movement in Shareholder Free Cash" is an estimate of shareholder free cashflow. Life and Invest and VitalityLife are included based on the change in the Adjusted Net Worth in the Embedded Value. Changes in working capital are not allowed for in the estimate. 1) This view of the movement in shareholder free cash flow aligns the dividend paid to the period against which the cash flow was generated to fund it. For 31 December 2024, the declared dividend of R591m, per the interim financial results, is used as the dividend accrued in respect of the six month period. 2) "Profit for the period" for H1 FY2024 and FY2023 has been restated as a result of prior period errors - refer to D.1.1 for more detail. The restatements do not affect the net Movement in Shareholder Free Cash Flow for those periods as they relate to movements in Vitality Life Limited's net assets under insurance contracts, which are non-cash flow movements. The offsetting adjustment has been included in "Increase in Negative Reserves and Invest DAC (Net of tax)" in the build-up above. -- 11 of 18 -- Reconciliation of operating profit to normalised operating profit for the six months ended 31 December 2024 Group Group R million Half-year ended December 2024 Half-year ended December 2023 change Operating profit 6 877 5 466 26% Share of net profits from equity accounted investments 399 278 Normalised profit from operations per Segment information (IFRS total) 7 276 5 744 27% Normalised profit adjustments ( 256) ( 208) Investment income earned on shareholder investments and cash ( 182) ( 139) Difference between market related rental and depreciation and finance costs (Head office) ( 96) ( 85) Net fair value gains on financial assets at fair value through profit or loss ( 78) ( 56) Amortisation of intangibles from business combinations 54 52 Restructuring costs 46 20 Normalised profit from operations 7 020 5 536 27% 12 Op Profit recon -- 12 of 18 -- Discovery Bank additional perforamance metrics for the six months ended 31 December 2024 2025 H1 2024 H2 2024 H1 2023 H2 2023 H1 Profitability and Efficiency Net Interest Margin (NIM) 10.08% 10.11% 9.84% 9.50% 9.07% Asset Quality Non-Performing Loan (NPL) Ratio 5.48% 5.84% 4.16% 7.44% 4.67% Capital Adequacy Common Equity Tier 1 (CET1) Ratio 16.67% 17.63% 17.07% 16.82% 16.47% Liquidity Loan-to-Deposit Ratio (LDR) 37.05% 35.72% 34.48% 36.08% 23.46% -- 13 of 18 -- NAV PER ENTITY for the year ended June 2024 Covered businesses December 2024 NAV before adjustment to shareholder funds Health and Vitality 4 474 Life and Invest 34 211 VitalityHealth 9 992 VitalityLife 4 313 Non-covered business Bank, including DCS intangible asset and goodwill 8 004 Insure 2 369 PAHI 7 230 CMT 1 402 Limited (11 680) Other 4 329 Total NAV 64 644 -- 14 of 18 -- -- 15 of 18 -- PAHI performance metrics RMB million December 2024 December 2023 %change 2024 2023 %change New business PAHI total (100%) 2 088 1 764 18% 4 698 4 027 17% New business PAHI Own Licence 1 743 1 591 10% 3 994 3 721 7% New business PAHI Reinsurance 345 173 99% 704 306 130% New business PAHI total (25%) 522 441 18% 1 174 1 007 17% New business PAHI Own Licence 435 398 10% 998 930 7% New business PAHI Reinsurance 86 43 99% 176 77 130% Total written premium (100%) 10 998 9 014 22% 24 629 20 440 20% Written premium-own licence 7 452 6 535 14% 17 036 15 250 12% Written premium-reinsurance 3 545 2 479 43% 7 593 5 190 46% Earned premium (100%) 8 729 7 524 16% 16 525 14 809 12% Own License 8 286 7 130 16% 15 904 14 057 13% Reinsurance 443 395 12% 621 752 -17% PAHI profit before investment income and gains (100%) 306 356 -14% 1 420 1 122 27% PAHI investment income and gains (100%) 599 202 196% 1 018 518 97% PAHI pre-tax profit (100%) 906 559 62% 2 439 1 640 49% PAHI profit before income and gains (25%) 226 140 62% 609 410 49% Investible assets 24 338 21 571 13% 24 338 21 571 13% Full years (calendar year) Half-years (DSY reporting cycle) Note: PAHI reinsurance information has been provided as additional information. Going forward, only direct own license information will be provided, which aligns the respective metric with the economics of the business -- 16 of 18 -- -- 17 of 18 -- Normalised Return on Equity H1 FY2025 FY2024 H1 FY2024 FY2023 EARNINGS Net profit - attributable to: 4 329 7 364 3 278 - Ordinary shareholders 4 285 7 283 3 239 A - Preference shareholders 47 91 44 - Non-controlling interest (3) (10) (5) Earnings adjustments for ordinary shareholders 65 46 17 C=B-A Normalised headline earnings 4 350 7 329 3 256 B EQUITY Opening total equity 57 719 49 724 49 724 - Insurance Finance Reserve (733) (3 184) (3 184) - Perpetual preference share capital 779 779 779 - Non-controlling interest - 4 4 - Other equity 57 673 52 125 52 125 D Adjusted opening equity 57 673 52 125 52 125 E=D Closing total equity 64 644 57 719 53 140 49 724 - Insurance Finance Reserve 1 761 (733) (2 144) (3 184) - Perpetual preference share capital 779 779 779 779 - Non-controlling interest (3) - 4 4 - Other equity 62 107 57 673 54 501 52 125 F Adjusted closing equity 62 107 57 673 54 501 52 125 G=F Normalised adjusted closing equity 62 172 57 719 54 518 52 125 H=G+C Average normalised equity 59 923 54 922 53 322 I=(H+E)/2 RETURN ON EQUITY Full-year Half-year Normalised return on equity (annualised) 15.0% 13.3% 12.6% =B/I =(1+B/I)^2-1 -- 18 of 18 --